Vectus Biosystems Ltd has released a press release.
Vectus Biosystems: Half Yearly Report and Appendix 4D
Filed with ASX ·
6ix hasn’t read this filing yet.
Vectus Biosystems Limited on 6ix
Story so far
Earlier from Vectus Biosystems
- A Significant Milestone for VB0004
- Chairman & CEO Address to Shareholders
- Third S.A.D. Group Reviewed By Trial Safety Review Committee
- Response to ASX Price and Volume Query
- Update on Phase I Human Trial
Later from Vectus Biosystems
- Completion of Final S.A.D. Study and First M.A.D. Study
- Quarterly Activities Report & Appendix 4C
- Completion of Second M.A.D. Study for VB0004
- Completion of Phase Ia for VB0004
- Vectus - $3.5 million placement
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems